{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:40:46Z","timestamp":1786736446292,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jcrt.jcrt_696_16","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T08:32:53Z","timestamp":1540542773000},"page":"183","source":"Crossref","is-referenced-by-count":3,"title":["Brentuximab vedotin demonstrates an objective response in a patient with refractory CD30+ primary mediastinal B-cell lymphoma"],"prefix":"10.4103","volume":"16","author":[{"given":"Nabeel","family":"Badri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KyariSumayin","family":"Ngamdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Torabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Guar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.244231-1","first-page":"349","volume-title":"Primary mediastinal B-cell lymphoma","author":"Johnson","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key-10.4103\/0973-1482.244231-2","first-page":"2253","volume-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.244231-3","first-page":"2319","volume-title":"Double-hit B-cell lymphomas","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.244231-4","first-page":"e555","volume-title":"Double-hit and double-protein-expression lymphomas: Aggressive and refractory lymphomas","author":"Sarkozy","year":"2015","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0973-1482.244231-5","first-page":"18374","volume-title":"MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma","author":"Lu","year":"2015","journal-title":"Oncotarget"},{"key":"key-10.4103\/0973-1482.244231-6","first-page":"598","volume-title":"Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma","author":"Li","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0973-1482.244231-7","first-page":"33","volume-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: Do they require a unique therapeutic approach?","author":"Dunleavy","year":"2015","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.244231-8","first-page":"2328","volume-title":"Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: Results from a phase 2 clinical trial","author":"Zinzani","year":"2017","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.244231-9","first-page":"1394","volume-title":"Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed\/refractory DLBCL with variable CD30 expression","author":"Jacobsen","year":"2015","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.244231-10","first-page":"42","volume-title":"Brentuximab vedotin for treatment of non-hodgkin lymphomas: A systematic review","author":"Berger","year":"2017","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:41:55Z","timestamp":1786732915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_696_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["244231"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_696_16","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}